Skip to main content

Table 1 Clinical success and mortality [19]

From: Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

Drug Clinical success Mortality
Anidulafungin 77.5 % 20.8 %
Fluconazole 63.0 % 28.4 %
Caspofungin 76.1 % 33.8 %
Micafungin 76.0 % 39.2 %
\